Table 1 Serum concentrations of bone metabolism and inflammatory biomarkers in male and female Wistar rats following dietary vitamin D supplementation.

From: Effects of dietary vitamin D supplementation on bone microarchitecture, mineralization, and mechanical properties in Wistar rat animal model

 

Male

Female

0 IU

1000 IU

5000 IU

0 IU

1000 IU

5000 IU

GH, ng/ml

10.73 ± 1.08a

8.90 ± 1.61a

10.62 ± 2,19a

4.48 ± 1.06b

5.63 ± 1.09b

5.96 ± 1.25b

OC, ng/ml

13.53 ± 4.40c

20.08 ± 6.59b

17.57 ± 2.70b

26.93 ± 8.87b

30.44 ± 6.81a

13.22 ± 3.82c

OPG, pg/ml

549.96 ± 84.98a

479.13 ± 74.80b

509.08 ± 136.39b

443.49 ± 133.82b

347.29 ± 66.07c

452.36 ± 90.54b

RANKL, pg/ml

36.78 ± 8.99b

63.34 ± 16.86a

49.67 ± 15.62b

53.65 ± 20.41a

40.71 ± 15.22b

35.42 ± 10.07b

IGF-1, ng/ml

921.77 ± 115.57

884.64 ± 191.21

1067.35 ± 150.89

953.70 ± 100.35

982.55 ± 73.12

887.32 ± 197.15

IL-1, pg/ml

20.05 ± 4.46

17.53 ± 1.09

19.23 ± 3.64

18.45 ± 1.74

19.57 ± 1.13

19.39 ± 0.43

IL-6, pg/ml

23.16 ± 4.49

18.90 ± 5.35

23.29 ± 5.83

18.72 ± 3.46

18.89 ± 6.33

18.95 ± 1.91

IL-10, pg/ml

41.15 ± 6.46b

84.14 ± 12.34a

39.50 ± 5.02b

16.83 ± 9.16c

15.90 ± 5.07c

35.25 ± 5.71b

TNFα, pg/ml

43.48 ± 8.41a

32.85 ± 3.03b

39.89 ± 5.87a

28.21 ± 2.50c

22.26 ± 1.04d

32.71 ± 2.49b

BALP, ng/ml

8.20 ± 2.52

9.41 ± 3.26

9.27 ± 3.09

6.89 ± 0.26

8.94 ± 3.29

9.38 ± 3.32

RANKL/OPG

0.067 ± 0.01c

0.132 ± 0.03a

0.098 ± 0.01c

0.118 ± 0.01b

0.115 ± 0.03b

0.079 ± 0.01c

  1. Data are shown as mean ± SEM with statistical significance set at p < 0.05. Different lowercase letters indicate statistically significant differences between groups. GH - Growth Hormone, OC - Osteocalcin, OPG – Osteoprotegrin, RANKL - Receptor Activator of Nuclear Factor κB Ligand, IGF-1 - Insulin-like Growth Factor 1, IL-1 – Interleukin 1, IL-6 – Interleukin 6, IL-10 – Interleukin 10, TNFα - Tumor Necrosis Factor alpha, BALP - Bone-specific Alkaline Phosphatase.